Skip to main content

Table 1 (abstract P46). Rates of AEs

From: Proceedings of the 2018 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting

  TCZ 12 mg/kg IV every 2 weeks
  Main Evaluation Period
n = 11
Optional Extension Period
n = 7
Entire Study Period
n = 11
Total patient-years at risk 2.3 5.1 7.4
Number of events (AE rate per 100 patient-years at risk)
 Any AE 32 (1396.4) 47 (926.5) 79 (1072.7)
 Serious AE 5 (218.2) 2 (39.4) 7 (95.1)
 AE with fatal outcome 0 0 0
 AE leading to withdrawal 4 (174.6) 1 (19.7) 5 (67.9)
 AE leading to dose interruption 1 (43.6) 12 (236.5) 13 (176.5)